Bio-Rad Labs (BIO) Misses Q1 EPS by 46c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.11 -0.39%
EPS Growth %: -30.7%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -30.7%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $3.34, $0.46 worse than the analyst estimate of $3.80. Revenue for the quarter came in at $677 million versus the consensus estimate of $696.08 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- What Delta’s report tells investors in American and United
- Piper Sandler on FirstSun Capital Bancorp (FSUN): 'We expect shares to underperform on Friday'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
